Health regulators have warned against the use or dispensing of recalled drugs Semaglutide and Tirzepatide.
The two medications are aimed at treating diabetes but are being used for weight loss purposes.
“The South African Pharmacy Council, Health Professions Council of South Africa and the South African Health Products Regulatory Authority hereby warn the public, pharmacies and dispensing medical practitioners against any continued use, prescription and/or dispensing of iDEXIS Semaglutide, iDEXIS Tirzepatide, and iDEXIS Semaglutide/Tirzepatide recalled by SAHPRA in June 2026.
“The continued use, prescription and dispensing of these products pose a severe risk to patients’ safety and/or users. Any healthcare professional found to have dispensed, prescribed or kept stock of the recalled products will face disciplinary action in accordance with applicable legislation, including the Medicines and Related Substances Act, 101 of 1965,” the authorities warned in a statement.
The authorities added that any professional prescribing or dispensing the medications will “knowingly be endangering the health of the public”. – SAnews.gov.za
